Assessment of the efficacy of drug transdermal delivery by electro-phonophoresis in treating tuberculous lymphadenitis

References

• American Thoracic CDC, Infectious Diseases Society of America. (2003). Treatment of tuberculosis. MMWR Recomm Rep 52:1–77
   Google Scholar
• Becker BM, Helfrich S, Baker E, et al. (2005). Ultrasound with topical anesthetic rapidly decreases pain of intravenous cannulation. Acad Emerg Med 12:289–95
   PubMed Web of Science ®Google Scholar
• Brown MB, Martin GP, Jones SA, Akomeah FK. (2006). Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv 13:175–87
   PubMed Web of Science ®Google Scholar
• Donnelly RF, Singh TRR, Woolfson AD. (2010). Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv 17:187–207
   PubMed Web of Science ®Google Scholar
• Elliott AM, Berning SE, Iseman MD, Peloquin CA. (1995). Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyema. Tuber Lung Dis 76:463–7
   PubMedGoogle Scholar
• Fontanilla JM, Barnes A, von Reyn CF. (2011). Current diagnosis and management of peripheral tuberculous lymphadenitis. Clin Infect Dis 53:555–62
   PubMed Web of Science ®Google Scholar
• Jutte PC, Rutgers SR, Van Altena R, et al. (2004). Penetration of isoniazid, rifampicin and pyrazinamide in tuberculous pleural effusion and psoas abscess. Int J Tuberc Lung Dis 8:1368–72
   PubMed Web of Science ®Google Scholar
• Kost J, Pliquett U, Mitragotri S, et al. (1996). Synergistic effect of electric field and ultrasound on transdermal transport. Pharm Res 13:633–8
   PubMed Web of Science ®Google Scholar
• Krishnan G, Grice JE, Roberts MS, et al. (2013). Enhanced sonophoretic delivery of 5-aminolevulinic acid: preliminary human ex vivo permeation data. Skin Res Technol 19:e283–9
   PubMed Web of Science ®Google Scholar
• Kumar K. (1992). The penetration of drugs into the lesions of spinal tuberculosis. Int Orthop 16:67–8
   PubMed Web of Science ®Google Scholar
• Maggi N, Pasqualucci CR, Ballotta R, Sensi P. (1966). Rifampicin: a new orally active rifamycin. Chemotherapy 11:285–92
   PubMed Web of Science ®Google Scholar
• Mitragotri S. (2005). Innovation: healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat Rev Drug Discov 4:255–60
   PubMed Web of Science ®Google Scholar
• Olu-eddo AN, Omoti CE. (2011). Diagnostic evaluation of primary cervical adenopathies in a developing country. Pan Afr Med J 10:52
   PubMedGoogle Scholar
• Paudel KS, Milewski M, Swadley CL, et al. (2010). Challenges and opportunities in dermal/transdermal delivery. Ther Deliv 1:109–131
   PubMedGoogle Scholar
• Polat BE, Hart D, Langer R, Blankschtein D. (2011). Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends. J Control Release 152:330–48
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Bose VG, Langer R, Weaver JC. (1993). Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA 90:10504–8
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Langer R. (2008). Transdermal drug delivery. Nat Biotechnol 26:1261–8
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Mitragotri S, Langer R. (2004). Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 3:115–24
   PubMed Web of Science ®Google Scholar
• Pusch T, Pasipanodya JG, Hall RG 2nd, Gumbo T. (2014). Therapy duration and long-term outcomes in extra-pulmonary tuberculosis. BMC Infect Dis 14:115
   PubMed Web of Science ®Google Scholar
• Schoellhammer CM, Srinivasan S, Barman R, et al. (2015). Applicability and safety of dual-frequency ultrasonic treatment for the transdermal delivery of drugs. J Control Release 202:93–100
   PubMed Web of Science ®Google Scholar
• Skarbek-Borowska S, Becker BM, Lovgren K, et al. (2006). Brief focal ultrasound with topical anesthetic decreases the pain of intravenous placement in children. Pediatr Emerg Care 22:339–45
   PubMed Web of Science ®Google Scholar
• Thomas SN, Schudel A. (2015). Overcoming transport barriers for interstitial-, lymphatic-, and lymph node-targeted drug delivery. Curr Opin Chem Eng 7:65–74
   PubMed Web of Science ®Google Scholar
• van Crevel R, Alisjahbana B, de Lange WC, et al. (2002). Low plasma concentrations of rifampicin in tuberculosis patients in Indonesia. Int J Tuberc Lung Dis 6:497–502
   PubMed Web of Science ®Google Scholar
• Wiedersberg S, Guy RH. (2014). Transdermal drug delivery: 30+ years of war and still fighting! J Control Release 190:150–6
   PubMed Web of Science ®Google Scholar
• Zhang Z, Dai F, Luo F, et al. (2014). Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis. J Orthop Surg Res 9:124. doi: 10.1186/s13018-014-0124-1
   PubMed Web of Science ®Google Scholar
• Zorec B, Becker S, Rebersek M, et al. (2013). Skin electroporation for transdermal drug delivery: the influence of the order of different square wave electric pulses. Int J Pharm 457:214–23
   PubMed Web of Science ®Google Scholar